Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Effects of 0.01 mM strontium on human periodontal ligament stem cell osteogenic differentiation via the Wnt/<b>β</b>-catenin signaling pathway

Sun T., Ma D., Song Y., Hu J., Yang Z., Wang X.

Laboratory Study on Ligament Injury, published in J Int Med Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Int Med Res (2025)
Reported sample size
—
Source database
Europe PMC
PMID
39932304
PMCID
PMC11815949
DOI
10.1177/03000605251315024
Citations
1

Abstract (original English)

Objectives Strontium (Sr 2+ ) is a crucial trace element in humans, mainly present in the bones. We investigated the effects of Sr 2+ on human periodontal ligament stem cell (hPDLSC) proliferation and osteogenesis and the relevant pathways. Methods hPDLSCs were harvested from extracted premolars and characterized by flow cytometry, then cultured and treated with various Sr 2+ concentrations. Cell-counting kit-8 (CCK-8) assays were used to assess hPDLSC proliferation, with alkaline phosphatase (ALP) staining, Alizarin red S staining, and ALP activity assays used to analyze their osteogenic capacity. Quantitative reverse transcription polymerase chain reaction and western blots were used to examine the expression levels of relevant factors, such as collagen I (COL-1), ALP, and Runx family transcription factor 2 (RUNX2). Moreover, tankyrase inhibitor XAV939 treatment was used to investigate the role of Sr 2+ in the canonical Wnt/β-catenin signaling pathway. Results The hPDLSCs were successfully isolated and cultured in vitro . A 0.01 mM Sr 2+ concentration significantly enhanced hPDLSC proliferation and osteogenic differentiation. However, XAV939-mediated inhibition of the canonical Wnt/β-catenin pathway could reverse the Sr 2 + -induced osteogenic effects. Conclusions Sr 2+ can enhance hPDLSC proliferation and osteogenesis by stimulating canonical Wnt/β-catenin signaling, suggest

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cells, CulturedStem CellsPeriodontal LigamentHumansStrontiumHeterocyclic Compounds, 3-RingAlkaline PhosphataseCell DifferentiationCell ProliferationOsteogenesis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research